Investor profile
Cambridge Angels
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Cambridge Angels is a leading UK business angel network — founded in 2001 and invitation-only — providing 'smart capital from entrepreneurs to entrepreneurs.' Membership is capped at 65 high-net-worth, largely exited entrepreneurs with deep expertise in tech and healthcare, who invest their own capital directly into early-stage companies raising £150k–£1.5m. The group charges no pitching or carry fees to founders and operates within the Cambridge 'Silicon Fen' ecosystem, leveraging the University of Cambridge and a network of six corporate VC members for later-stage follow-on. The network has a particular focus on deep tech and tools and technologies supporting healthcare, though it backs a wide range of science- and engineering-driven startups across the UK. Beyond capital, members provide hands-on strategic mentorship, operational expertise, and access to a peer community of portfolio founders, with the goal of helping companies scale and achieve strong exits.
Notable quotes
“Early-stage investing really is a labour of love. You go in at low valuations, you do a huge amount of work helping a company get to a meaningful inflection point, and then when institutional capital arrives with preference stacks and larger cheques, the economics don't always reflect the risk you took at the start.”
“Sharing talent, recommendations and experiences with other founders who are at the same stage or at a more advanced stage is like having Cambridge Angels Google.”
“What makes Cambridge Angels different for me is the mix of trust and experience. Inside the room is very open. You can say 'I don't understand this' or 'I'm worried about that' without feeling stupid, because someone else has almost certainly been through it.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Orthofuse | Seed | $3m | 2026-02 |
| AVIEL Intelligence | Seed | $470k | 2025-04 |
| Qureight | Series A | $8m | 2024-04 |
| Xampla | Other Equity | $7m | 2024-01 |
| Healx | Seed | — | — |
| Paragraf | Seed | — | — |
| Privitar | Seed | — | — |
| Closed Loop Medicine | Series A | $18m | 2021-11 |
| CyberSmart | Seed | — | — |
| Exonate | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Amadeus Capital Partners | 5 |
| Parkwalk Advisors | 5 |
| Cambridge Enterprise | 4 |
| Playfair Capital | 4 |
| ACF Investors | 3 |
| Martlet Capital | 3 |
Fit check
Is Cambridge Angels a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit